STAGE 1 1mg strength 1
The perceived difference may stem from psychological factors rather than pharmacological differencespatients may expect the injection site closest to the digestive system to work faster, even when absorption timing is essentially identical
Aside from your baseline body weight, higher doses tend to be administered or adjusted during the program based on a patients varying needs
Numerous GLP-1RAs have been developed and utilized in the treatment of type 2 diabetes as injections (liraglutide, exenatide (exendin-4 (Ex-4)), lixisenatide, semaglutide, etc
In addition, substitutions of the terminal sulfonamide moiety raised the lipophilicity of these derivatives, which helped them cross the BBB, although the activity was reduced when large functional groups were connected to the sulfonamide moiety
In addition, GLP-1 inhibits gastric emptying and induces satiety [84, 85]